Search Within

Dmitriy Zamarin

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (23)
  3. Book Section (1)
  4. Guidelines (1)
Groups
  1. Department of Medicine (53)
  2. GDMT, Medicine (53)
  3. Gynecologic Medicine Service (53)
  4. Gynecology Disease Management Team (53)
  5. Hematologic Malignancies, Division of (53)
  6. Solid Tumor Oncology Division (53)

More Groups

People
  1. Roisin O'Cearbhaill (42)
  2. Carol Aghajanian (39)
  3. Rachel Grisham (23)
  4. Alexia Iasonos (22)
  5. Claire Friedman (21)
  6. Jason Konner (21)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2022 (9)
  4. 2021 (4)
  5. 2020 (9)
  6. 2019 (7)

More Years

Publications
  1. Gynecologic Oncology (16)
  2. Journal of Clinical Oncology (13)
  3. Clinical Cancer Research (3)
  4. International Journal of Gynecological Cancer (3)
  5. Blood (2)
  6. Cell (2)

More Publications

Publishers
  1. Elsevier Inc. (17)
  2. American Society of Clinical Oncology (15)
  3. American Association for Cancer Research (4)
  4. Lippincott Williams & Wilkins (4)
  5. Nature Publishing Group (3)
  6. American Society of Hematology (2)

More Publishers

Results (53)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
    Journal Article

    Lu, S. X.; De Neef, E.; Thomas, J. D.; Sabio, E.; Rousseau, B.; Gigoux, M.; Knorr, D. A.; Greenbaum, B.; Elhanati, Y.; Hogg, S. J.; more...
    Cell (2021)

    Fulltext@MSK | Save
  • A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
    Journal Article

    Rubinstein, M. M.; Grisham, R. N.; Cadoo, K.; Kyi, C.; Tew, W. P.; Friedman, C. F.; O'Cearbhaill, R. E.; Zamarin, D.; Zhou, Q.; Iasonos, A.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Pattern of disease in recurrent cervical cancer associated with response to pembrolizumab
    Meeting Abstract

    Miller, K.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Jewell, E. L.; Kyi, C.; Lakhman, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; McDonnell, A.; Iasonos, A.; Zhou, Q.; Li, K.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Aghajanian, C.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer
    Meeting Abstract

    Friedman, C. F.; Snyder, A.; Abu-Rustum, N. R.; Broach, V.; Brown, C. L.; Bykov, Y.; Cadoo, K. A.; Chi, D. S.; Cohen, S.; Eid, K. T.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Gastric-type adenocarcinoma of the cervix: Genomic drivers and clinical outcomes
    Meeting Abstract

    Sassine, D.; Straubhar, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Kyi, C.; Leitao, M. M.; Mueller, J. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • BRCA mutations, homologous DNA repair deficiency, tumor mutational burden, and response to immune checkpoint inhibition in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Selenica, P.; Zhou, Q.; Iasonos, A.; Callahan, M.; Feit, N. Z.; Boland, J.; Vazquez-Garcia, I.; Mandelker, D.; Zehir, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
    Journal Article

    Boland, J. L.; Zhou, Q.; Iasonos, A. E.; O'Cearbhaill, R. E.; Konner, J.; Callahan, M.; Friedman, C.; Aghajanian, C.; Sabbatini, P.; Zamarin, D.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer
    Journal Article

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; O'Cearbhaill, R.; Aghajanian, C. A.; Schilder, R.
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial
    Journal Article

    Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save